96 related articles for article (PubMed ID: 18286397)
1. Effectiveness of mirtazapine in the treatment of depression with associated somatic symptoms.
García Campayo J
Actas Esp Psiquiatr; 2008; 36(1):25-32. PubMed ID: 18286397
[TBL] [Abstract][Full Text] [Related]
2. Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.
Kang EH; Lee IS; Chung SK; Lee SY; Kim EJ; Hong JP; Oh KS; Woo JM; Kim S; Park JE; Yu BH
Psychiatry Res; 2009 Sep; 169(2):118-23. PubMed ID: 19695711
[TBL] [Abstract][Full Text] [Related]
3. The effect of mirtazapine in patients with chronic pain and concomitant depression.
Freynhagen R; Muth-Selbach U; Lipfert P; Stevens MF; Zacharowski K; Tölle TR; von Giesen HJ
Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597
[TBL] [Abstract][Full Text] [Related]
4. The level of recognition of physical symptoms in patients with a major depression episode in the outpatient psychiatric practice in Puerto Rico: an observational study.
Tamayo JM; Román K; Fumero JJ; Rivas M
BMC Psychiatry; 2005 Jun; 5():28. PubMed ID: 15967039
[TBL] [Abstract][Full Text] [Related]
5. Mirtazapine for treatment-resistant depression: a preliminary report.
Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
Kim JE; Yoon SJ; Kim J; Jung JY; Jeong HS; Cho HB; Shin E; Lyoo IK; Kim TS
Int J Clin Pract; 2011 Mar; 65(3):323-9. PubMed ID: 21314870
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorder.
Kasper S; Montgomery SA; Möller HJ; van Oers HJ; Jan Schutte A; Vrijland P; van der Meulen EA
World J Biol Psychiatry; 2010 Feb; 11(1):36-44. PubMed ID: 20146649
[TBL] [Abstract][Full Text] [Related]
8. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
[TBL] [Abstract][Full Text] [Related]
9. Mirtazapine in the treatment of adolescents with major depression: an open-label, multicenter pilot study.
Haapasalo-Pesu KM; Vuola T; Lahelma L; Marttunen M
J Child Adolesc Psychopharmacol; 2004; 14(2):175-84. PubMed ID: 15319015
[TBL] [Abstract][Full Text] [Related]
10. Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study.
Yoon SJ; Pae CU; Kim DJ; Namkoong K; Lee E; Oh DY; Lee YS; Shin DH; Jeong YC; Kim JH; Choi SB; Hwang IB; Shin YC; Cho SN; Lee HK; Lee CT
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1196-201. PubMed ID: 16624467
[TBL] [Abstract][Full Text] [Related]
11. Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients.
Mühlbacher M; Konstantinidis A; Kasper S; Eichberger G; Hinterhuber H; Hofmann P; Nimmerrichter A; Schubert H; Egger C; Nickel M; Stuppaeck C
Neuropsychobiology; 2006; 53(2):83-7. PubMed ID: 16511339
[TBL] [Abstract][Full Text] [Related]
12. An open-label study of mirtazapine as treatment for combat-related PTSD.
Alderman CP; Condon JT; Gilbert AL
Ann Pharmacother; 2009 Jul; 43(7):1220-6. PubMed ID: 19584388
[TBL] [Abstract][Full Text] [Related]
13. Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.
Varia I; Venkataraman S; Hellegers C; Gersing K; Doraiswamy PM
Psychopharmacol Bull; 2007; 40(1):47-56. PubMed ID: 17285095
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and association of somatic symptoms in patients with Major Depressive Disorder.
Vaccarino AL; Sills TL; Evans KR; Kalali AH
J Affect Disord; 2008 Oct; 110(3):270-6. PubMed ID: 18280580
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
Fawcett J; Barkin RL
J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
[TBL] [Abstract][Full Text] [Related]
16. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.
Schüle C; Baghai TC; Eser D; Nothdurfter C; Rupprecht R
World J Biol Psychiatry; 2009; 10(4 Pt 2):390-9. PubMed ID: 18609420
[TBL] [Abstract][Full Text] [Related]
17. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
[TBL] [Abstract][Full Text] [Related]
19. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
[TBL] [Abstract][Full Text] [Related]
20. Interaction of 5-HTT and HTR1A gene polymorphisms in treatment responses to mirtazapine in patients with major depressive disorder.
Chang HS; Lee HY; Cha JH; Won ES; Ham BJ; Kim B; Lee MS
J Clin Psychopharmacol; 2014 Aug; 34(4):446-54. PubMed ID: 24911443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
